The evolution of nasopharyngeal carcinoma staging
- PMID: 31298937
- PMCID: PMC6774596
- DOI: 10.1259/bjr.20190244
The evolution of nasopharyngeal carcinoma staging
Abstract
The prevalence of nasopharyngeal carcinoma is characterized by an unbalanced distribution: the disease is particularly prevalent in East and Southeast Asia. In this article, we review the evolution of the International Union Against Cancer/American Joint Committee on Cancer staging system for nasopharyngeal carcinoma. With the increasing using of newer imaging methods, more advanced radiotherapy techniques and systemic chemotherapy, we also discuss newer clinical features that might affect staging. Finally, we propose the future direction of staging and potential prognostic factors that have a major influence on the treatment outcomes of this disease.
Figures
References
-
- Kattan MW, Hess KR, Amin MB, Lu Y, Moons KGM, Gershenwald JE, et al. . American Joint Committee on Cancer acceptance criteria for inclusion of risk models for individualized prognosis in the practice of precision medicine. CA Cancer J Clin 2016; 66: 370–4. doi: 10.3322/caac.21339 - DOI - PMC - PubMed
-
- WT N, Yuen KT, KH A, et al. . Staging of nasopharyngeal carcinoma - The past, the present and the future. Oral Oncol 2013;. - PubMed
-
- Sobin LH WC. International Union Against Cancer (UICC): TNM classification of malignant tumours. In: Wiley-Liss New York:, ed. 5th; 1997.
